Arena Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This ESG assessment for Arena Pharmaceuticals Inc indicates the company's transparency towards the UN SDGs. Comprehensive ESG assessment of Arena Pharmaceuticals Inc can be accessed by registering for free. Check the end of the webpage for potential risks for Arena Pharmaceuticals Inc based on sector, location and marketcap.
Arena Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Arena Pharmaceuticals Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Arena Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does Arena Pharmaceuticals Inc disclose current and historical energy intensity?
Does Arena Pharmaceuticals Inc report the average age of the workforce?
Does Arena Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does Arena Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Arena Pharmaceuticals Inc disclose cybersecurity risks?
Does Arena Pharmaceuticals Inc offer flexible work?
Does Arena Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Arena Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does Arena Pharmaceuticals Inc conduct supply chain audits?
Does Arena Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Arena Pharmaceuticals Inc conduct 360 degree staff reviews?
Does Arena Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Arena Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Arena Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does Arena Pharmaceuticals Inc disclose water use targets?
Does Arena Pharmaceuticals Inc have careers partnerships with academic institutions?
Did Arena Pharmaceuticals Inc have a product recall in the last two years?
Does Arena Pharmaceuticals Inc disclose incidents of discrimination?
Does Arena Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has Arena Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Arena Pharmaceuticals Inc disclose parental leave metrics?
Does Arena Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Arena Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Arena Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Arena Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Arena Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Arena Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Arena Pharmaceuticals Inc involved in embryonic stem cell research?
Does Arena Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does Arena Pharmaceuticals Inc disclose its waste policy?
Does Arena Pharmaceuticals Inc report according to TCFD requirements?
Does Arena Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Arena Pharmaceuticals Inc disclose energy use targets?
Does Arena Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Arena Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Arena Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase I clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with Second Genome, Inc.; United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; Eisai Inc.; and Aristea Therapeutics, Inc. for the development of RIST4721 for treatment of serious immune-mediated inflammatory diseases. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah.